Literature DB >> 28846967

Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis.

Islam Eid1, Mohamed M Elsebaei1, Haroon Mohammad2, Mohamed Hagras1, Christine E Peters3, Youssef A Hegazy2, Bruce Cooper4, Joe Pogliano3, Kit Pogliano3, Hamada S Abulkhair1, Mohamed N Seleem5, Abdelrahman S Mayhoub6.   

Abstract

The promising antibacterial potency of arylthiazole antibiotics is offset by their limited activity against intracellular bacteria (namely n class="Chemical">methicillin-resistant Staphylococcus aureus (MRSA)), similar to many clinically-approved antibiotics. The failure to target these hidden pathogens is due to the compounds' lack of proper characteristics to accumulate intracellularly. Fine tuning of the size and polar-surface-area of the linking heteroaromatic ring provided a new series of 5-thiazolylarylthiazoles with balanced properties that allow them to sufficiently cross and accumulate inside macrophages infected with MRSA. The most promising compound 4i exhibited rapid bactericidal activity, good metabolic stability and produced over 80% reduction of intracellular MRSA in infected macrophages.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antibiotic drug resistance; Caenorhabditis elegans; Intracellular infection; MRSA; Methicillin-resistant Staphylococcus aureus; Pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 28846967      PMCID: PMC5911928          DOI: 10.1016/j.ejmech.2017.08.039

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  19 in total

1.  Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus.

Authors:  Haroon Mohammad; Abdelrahman S Mayhoub; Adil Ghafoor; Muhammad Soofi; Ruba A Alajlouni; Mark Cushman; Mohamed N Seleem
Journal:  J Med Chem       Date:  2014-01-14       Impact factor: 7.446

2.  Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability.

Authors:  Mohamed Hagras; Youssef A Hegazy; Amr H Elkabbany; Haroon Mohammad; Adel Ghiaty; Tamer M Abdelghany; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  Eur J Med Chem       Date:  2017-10-19       Impact factor: 6.514

3.  The Bacillus subtilis cannibalism toxin SDP collapses the proton motive force and induces autolysis.

Authors:  Anne Lamsa; Wei-Ting Liu; Pieter C Dorrestein; Kit Pogliano
Journal:  Mol Microbiol       Date:  2012-04-02       Impact factor: 3.501

4.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.

Authors:  Paulina Schmitt; Miriam Wilmes; Martine Pugnière; André Aumelas; Evelyne Bachère; Hans-Georg Sahl; Tanja Schneider; Delphine Destoumieux-Garzón
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

6.  Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.

Authors:  Koneni V Sashidhara; K Bhaskara Rao; Pragati Kushwaha; Ram K Modukuri; Pratiksha Singh; Isha Soni; P K Shukla; Sidharth Chopra; Mukesh Pasupuleti
Journal:  ACS Med Chem Lett       Date:  2015-05-29       Impact factor: 4.345

7.  Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA).

Authors:  Mohamed Hagras; Haroon Mohammad; Mohamed S Mandour; Youssef A Hegazy; Adel Ghiaty; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  J Med Chem       Date:  2017-05-01       Impact factor: 7.446

8.  Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.

Authors:  Oleg Krut; Herdis Sommer; Martin Krönke
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

9.  Second-Generation Phenylthiazole Antibiotics with Enhanced Pharmacokinetic Properties.

Authors:  Mohammed A Seleem; Ahmed M Disouky; Haroon Mohammad; Tamer M Abdelghany; Ahmed S Mancy; Sammar A Bayoumi; Ahmed Elshafeey; Ahmed El-Morsy; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  J Med Chem       Date:  2016-05-17       Impact factor: 7.446

10.  Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.

Authors:  Haroon Mohammad; P V Narasimha Reddy; Dennis Monteleone; Abdelrahman S Mayhoub; Mark Cushman; G Kenitra Hammac; Mohamed N Seleem
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

View more
  7 in total

1.  Exploration of NMI-MsCl mediated amide bond formation for the synthesis of novel 3,5-substituted-1,2,4-oxadiazole derivatives: synthesis, evaluation of anti-inflammatory activity and molecular docking studies.

Authors:  B Kulkarni; K Manjunatha; Muthipeedika Nibin Joy; Ayyiliath Meleveetil Sajith; Sougata Santra; Grigory V Zyryanov; C N Prashantha; Mohammed B Alshammari; K Sunil
Journal:  Mol Divers       Date:  2022-10-11       Impact factor: 3.364

2.  Design, synthesis and molecular docking studies of some 1-(5-(2-fluoro-5-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-3-yl)piperazine derivatives as potential anti-inflammatory agents.

Authors:  B Kulkarni; K Manjunatha; Muthipeedika Nibin Joy; Ayyiliath Meleveetil Sajith; C N Prashantha; Ranjith Pakkath; Mohammed B Alshammari
Journal:  Mol Divers       Date:  2021-11-24       Impact factor: 3.364

3.  Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.

Authors:  Abdallah Turky; Ashraf H Bayoumi; Farag F Sherbiny; Khaled El-Adl; Hamada S Abulkhair
Journal:  Mol Divers       Date:  2020-08-23       Impact factor: 2.943

4.  Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mohamed M Elsebaei; Haroon Mohammad; Mohamed Abouf; Nader S Abutaleb; Youssef A Hegazy; Adel Ghiaty; Lu Chen; Jianan Zhang; Satish R Malwal; Eric Oldfield; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  Eur J Med Chem       Date:  2018-02-12       Impact factor: 6.514

Review 5.  Peptidoglycan pathways: there are still more!

Authors:  Ahmed M Helal; Ahmed M Sayed; Mariam Omara; Mohamed M Elsebaei; Abdelrahman S Mayhoub
Journal:  RSC Adv       Date:  2019-09-09       Impact factor: 4.036

6.  tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity.

Authors:  Ahmed Kotb; Nader S Abutaleb; Mohamed Hagras; Ashraf Bayoumi; Mahmoud M Moustafa; Adel Ghiaty; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  RSC Adv       Date:  2019-02-26       Impact factor: 4.036

7.  Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris.

Authors:  Haroon Mohammad; Hassan E Eldesouky; Tony Hazbun; Abdelrahman S Mayhoub; Mohamed N Seleem
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.